Thiophene-based lipids

US2024300972A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2024300972-A1
Application numberUS-202418617043-A
CountryUS
Kind codeA1
Filing dateMar 26, 2024
Priority dateSep 27, 2021
Publication dateSep 12, 2024
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed herein are compounds according to Formula A wherein the compound comprises at least one C 6-30 aliphatic moiety. Also disclosed are compositions comprising the compounds that may be useful for delivering agents such as therapeutic and/or prophylactic agents, for example, nucleic acids such as, but not limited to, DNA or RNA, small molecules, proteins, polypeptides or peptides. In some embodiments, the composition is a lipid nanoparticle. Also disclosed herein are lipid nanoparticles comprising the compounds and methods for making and using the nanoparticles.

First claim

Opening claim text (preview).

We claim: 1 . A compound according to Formula A wherein: X is a bond, —C(O)O—, —OC(O)—, —NH—, —N(R 1 )—, —C(O)N(R 1 )—, —N(R 1 )C(O)—, —C(O)NH—, —NHC(O)—, —C≡C—, —CH═CH—, —O—, —S—, —NHC(O)NH—, —OC(O)O—, —OC(O)NH—, —NHC(O)O—, —O(CH 2 ) m or —(CH 2 ) m O—; m is from 0 to 6; each R 1 is H, halogen, CN, or aliphatic; R 2 is H, halogen, aromatic, or aliphatic; or X is a bond and R 1 and R 2 , together with the atoms to which there are attached, form a 4- to 7-membered nitrogen-containing non-aromatic heterocyclyl; R A3 is halogen, R 3 , —C(O)N(R 6 )(R 7 ), —C(O)R 3 , —CN, —(CH 2 ) r N(R 6 )(R 7 ), —N(R 6 )(R 7 ), —S(O)R d , —S(O)R 3 , —CH 2 SR d , —CH 2 R 3 , —S(O)N(R 6 )(R 7 ), or —X 1 (CH 2 ) r N(R a ) 2 ; X 1 is O, S or NH; r is from 1 to 8; each R a independently is H, C 1-6 alkyl, C 3-6 cycloalkyl, or both R a s together with the nitrogen to which they are attached form a 5- or 6-membered heterocyclyl; R 3 is aliphatic, —O-aliphatic or N(R 6 )(R 7 ); R A4 is halogen, boronic acid, —N(R 4 )(R 5 ), NHC(O)N(R 4 )(R 5 ), —N═CHR d , —NHC(S)N(R 4 )(R 5 ), —NHC(O)(CH 2 ) z —N(R 4 )(R 5 ), —NHSO 2 R d , —NHS(O)R d , —NHC(O)C(O)NH(CH 2 ) z —N(R 4 )(R 5 ), or —OR 4 , where z is an integer from 1 to 6; each R d is aliphatic; R 4 is aliphatic or —C(O)aliphatic; R 5 is H, aliphatic, or —C(O)aliphatic; R 6 is H or aliphatic; R 7 is aliphatic or C(O)aliphatic; or R 6 and R 7 , together with the atom to which there are attached, form a 4- to 7-membered nitrogen-containing heterocyclyl; and wherein the compound comprises at least one C 6-30 aliphatic moiety. 2 . The compound of claim 1 , wherein: R 6 is H or aliphatic; and R 7 is aliphatic or C(O)aliphatic. 3 . The compound of claim 1 , having a Formula I: wherein X is a bond, —NH—, —N(R 1 )—, or —OC(O)—. 4 . The compound of claim 1 , having a Formula I-A: 5 . The compound of claim 4 , wherein R 1 is aliphatic; R 2 is H or aliphatic; or R 1 and R 2 , together with the atoms to which there are attached, form a 5- to 7-membered nitrogen-containing non-aromatic heterocyclyl; R 3 is aliphatic, —O-aliphatic or N(R 6 )(R 7 ); R 4 is aliphatic or —C(O)aliphatic; R 5 is H, aliphatic or —C(O)aliphatic; R 6 is H or aliphatic; R 7 is aliphatic or C(O)aliphatic; and wherein the compound comprises at least one C 6-30 aliphatic moiety. 6 . The compound of claim 1 , wherein R 1 is C 6-30 aliphatic. 7 . The compound of claim 1 , wherein R 1 is C 6-10 aliphatic. 8 . The compound of claim 1 , wherein R 1 is C 1-6 alkyl and is substituted with N(R a ) 2 , where each R a independently is H or C 1-6 alkyl, or both R a s together with the nitrogen to which they are attached form an optionally substituted 5- or 6-membered heterocyclyl. 9 . The compound of claim 8 , wherein R 1 is —(CH 2 ) 14 N(R a ) 2 . 10 . The compound of claim 9 , wherein R 1 is —CH 2 NH 2 . 11 . The compound of claim 1 , wherein R 2 is H. 12 . The compound of claim 1 , wherein R 2 is C 6-30 aliphatic. 13 . The compound of claim 1 , wherein R 1 and R 2 are both C 6-30 aliphatic, and R 1 and R 2 are different. 14 . The compound of claim 1 , wherein the compound has a formula wherein each of R 1 and R 2 independently is C 6-30 aliphatic. 15 . The compound of claim 1 , wherein the compound has a formula wherein: each of R 1 and R 2 independently is C 6-30 aliphatic; each R a independently is H or C 1-6 alkyl, or both R a s together with the nitrogen to which they are attached form an optionally substituted 5- or 6-membered heterocyclyl; and s is an integer from 1 to 8. 16 . The compound of claim 1 , wherein the compound has a formula wherein: each of R 1 and R 2 independently is C 6-30 aliphatic; each R a independently is H or C 1-6 alkyl, or both R a s together with the nitrogen to which they are attached form an optionally substituted 5- or 6-membered heterocyclyl; and s is an integer from 1 to 8. 17 . The compound of claim 1 , wherein the compound has a formula wherein: each of R 1 and R 2 independently is C 6-30 aliphatic; and each R a independently is H or C 1-6 alkyl, or both R a s together with the nitrogen to which they are attached form an optionally substituted 5- or 6-membered heterocyclyl. 18 . The compound of claim 17 , wherein the compound has a formula 19 . The compound of claim 1 , wherein the compound has a formula wherein: each R a independently is H or C 1-6 alkyl, or both R a s together with the nitrogen to which they are attached form an optionally substituted 5- or 6-membered heterocyclyl; and s is an integer from 1 to 8. 20 . The compound of claim 19 , wherein the compound has a formula 21 . The compound of claim 15 , wherein s is an integer from 1, 2, 3 or 4. 22 . The compound of claim 8 , wherein each R a independently is C 1-6 alkyl. 23 . The compound of claim 16 , wherein: s is 2 or 3; each of R 1 and R 2 independently is C 6-10 alkyl; R 3 is O-methyl or O-ethyl; each R a independently is C 14 alkyl; or a combination thereof. 24 . The compound of claim 1 , wherein X is a bond and R 1 and R 2 , together with the atoms to which there are attached, form a 4- to 7-membered nitrogen-containing non-aromatic heterocyclyl; provided that the compound is not of the formula: or a salt thereof. 25 . The compound of claim 24 , wherein the compound has a formula II′: wherein: R 8 is H or R c ; and R c is -aliphatic, -aliphatic-amino, —C(O)-aliphatic, or —C(O)-aliphatic-amino. 26 . The compound of claim 24 , wherein the compound has a formula II: wherein: R 8 is H or Re; and R c is -aliphatic, -aliphatic-amino, —C(O)-aliphatic, or —C(O)-aliphatic-amino. 27 . The compound of claim 26 , wherein the compound has a formula II-a: 28 . The compound of claim 25 , wherein R

Assignees

Inventors

Classifications

  • C07D333/26Primary

    with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms · CPC title

  • Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca · CPC title

  • the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine · CPC title

  • having five-membered rings · CPC title

  • obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2024300972A1 cover?
Disclosed herein are compounds according to Formula A wherein the compound comprises at least one C 6-30 aliphatic moiety. Also disclosed are compositions comprising the compounds that may be useful for delivering agents such as therapeutic and/or prophylactic agents, for example, nucleic acids such as, …
Who is the assignee on this patent?
Univ Oregon State
What technology area does this patent fall under?
Primary CPC classification C07D333/26. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Sep 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).